Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
TEN, Ltd. Reports Profits for the Twelve-Months and Fourth Quarter Ended December 31, 2025
-
GraniteShares Announces Weekly Distributions for its YieldBOOST FoFs ETFs: YBST and YBTY
-
New England Journal of Medicine publishes phase III ALLEGORY data showing Roche’s Gazyva/Gazyvaro significantly reduces disease activity in the most common form of lupus
-
Reitar Logtech Signs Landmark US$60 Million Strategic Equity Investment Agreement at US$4.00 per Share Marking a Major New Milestone in the Global Logistics Sector
-
SEALSQ Announces Comprehensive 2026 Certification Roadmap for QS7001 Secure Element and QVault TPM Product Lines
-
Aethlon Medical to Present at the Life Sciences Investor Forum on March 12th
-
High Roller Announces Appointment of Andrew Walter as Chief Legal and Compliance Officer
-
Solid Biosciences Announces Oversubscribed $240 Million Private Placement
-
Solid Biosciences to Present at the 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
-
Reborn Coffee Appoints Jung Jae Lim as Co-Chief Executive Officer to Strengthen Supply Chain Execution and Drive New Growth
-
Form 8.3 Picton Property Income Limited
-
Rogers Announces Screen Break Unplug and Play Events Across Canada During March Break
-
Solid Biosciences to Present at the 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
-
GoldHaven Files NI 43-101 Technical Report for the District-Scale Magno Polymetallic Project, Cassiar District, British Columbia
-
Gymboree and Marchesa Introduce MARCHESA MINI X GYMBOREE, a Collection of Elevated Occasion-Wear
-
Join Off The Hook’s Exclusive Live Investor Webinar and Q&A Session on March 11
-
1847 Holdings Signs LOI to Acquire 40-Year Construction Contractor with $29 Million Backlog
-
Reliance Global Group Schedules Fourth Quarter 2025 Financial Results and Business Update Conference Call
-
Servier and Day One Biopharmaceuticals announce acquisition to expand Servier’s rare oncology portfolio
-
Gymboree and Marchesa Introduce MARCHESA MINI X GYMBOREE, a Collection of Elevated Occasion-Wear
-
DirectBooking Technology Co., Ltd. Announces Regained Compliance with Nasdaq Minimum Bid Price Requirement
-
Odysight.ai Partners with XP Services for First US Flight Testing of its AI-Predictive Maintenance System on UH-60 Helicopter
-
SunCar Forecasting Preliminary Unaudited 2025 Revenue of $498 million, Strong Q4 Growth of 24%, Second Half 2025 Profitability, and 20% Revenue Growth in 2026
-
Calidi Biotherapeutics Announces Pricing of $5.2 Million Underwritten Public Offering
-
Blue Hat Interactive Entertainment Technology Announces Share Repurchase Program
-
AMC Robotics Highlights AI Quadruped Robot at Tokyo Security Show 2026
-
Join Off The Hook’s Exclusive Live Investor Webinar and Q&A Session on March 11
-
Form 8.3 LondonMetric Property Plc
-
Form 8.3 British Land Co plc
-
Form 8.3 Augmentum Fintech Plc
-
Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2026 Annual General Meeting
-
HIGHCO: SHAREHOLDING
-
Luotea PLC - Managers' Transactions: Antti Niitynpää
-
Alpha Modus Secures Settlement in Ongoing AI Retail Technology Patent Enforcement Efforts
-
Catalyst Pharmaceuticals to Showcase Real‑World Findings in Duchenne Muscular Dystrophy and Host Vamorolone-Focused Symposium at the 2026 MDA Clinical & Scientific Conference
-
Catalyst Pharmaceuticals to Showcase Real‑World Findings in Duchenne Muscular Dystrophy and Host Vamorolone-Focused Symposium at the 2026 MDA Clinical & Scientific Conference
-
Blaze Pizza Celebrates Pi Day 2026 with Fan-Favorite $3.14 Buy One, Get One Deal
-
White Lodging Named 2026 Gallup Exceptional Workplace Award Winner
-
Brunswick Exploration Announces Upsized Non-Brokered Life Private Placement
-
Allarity Therapeutics Closes $20 Million Financing to Accelerate the Advance of Stenoparib Toward FDA Approval and Commercialization
-
Cohen & Company Reports Fourth Quarter & Full Year 2025 Financial Results
-
PMV Pharmaceuticals Reports Full Year 2025 Financial Results and Corporate Highlights
-
Adial Pharmaceuticals Reports 2025 Fiscal Year Financial Results and Provides Business Update
-
Aemetis to Review Fourth Quarter and Year End 2025 Financial Results on March 12, 2026
-
Artelo Biosciences Announces Reverse Stock Split
-
Anathapindika Shines Spotlight on World Sleep Day
-
Anathapindika Spotlight Shines on Rare Disease Day (and How Detoxification Can Help)
-
Hurco Reports First Quarter Results for Fiscal Year 2026
-
EagleNXT Announces Strategic Investment in Leading Israeli Precision Loitering Munition Innovator
-
Prenetics Authorizes $40 Million Share Repurchase Program
